Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neuroimaging and genetic risk for Alzheimer's disease and addiction-related degenerative brain disorders.

Brain imaging and behavior - 1 Jun 2014

Roussotte Florence F, Daianu Madelaine, Jahanshad Neda, Leonardo Cassandra D, Thompson Paul M

Abstract excerpt

Neuroimaging offers a powerful means to assess the trajectory of brain degeneration in a variety of disorders, including Alzheimer's disease (AD). Here we describe how multi-modal imaging can be used to study the changing brain during the different stages of AD. We integrate findings from a range of studies using magnetic resonance imaging (MRI), positron emission tomography (PET), functional MRI (fMRI) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Brain
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neurodegenerative Diseases

Share to Neuroimaging

Share to Substance-Related Disorders

Source

Open in PubMed Open full text

Identifiers

PMID: 24142306
DOI: 10.1007/s11682-013-9263-y
PMCID: PMC3992278

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neuroimaging and genetic risk for Alzheimer's disease and addiction-related degenerative brain disorders.PMID 24142306Read ↗

Linking Brain Imaging and Genomics in the Study of Alzheimer's Disease and AgingSemantic proximity Read ↗

Functional brain imaging to identify affected subjects genetically at risk for Alzheimer's disease.Semantic proximity Read ↗

Neuroimaging within the Dominantly Inherited Alzheimer’s Network (DIAN): PET and MRISemantic proximity Read ↗

Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN).Semantic proximity Read ↗

The Radiogenomics of Late-onset Alzheimer Disease.Semantic proximity Read ↗

Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer's disease.Semantic proximity Read ↗

Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease.Semantic proximity Read ↗

Does variation in neurodegenerative disease susceptibility and phenotype reflect cerebral differences at the network level?Semantic proximity Read ↗

Imaging genomics discovery of a new risk variant for Alzheimer's disease in the postsynaptic SHARPIN gene.Semantic proximity Read ↗

Revolution of Resting-State Functional Neuroimaging Genetics in Alzheimer's Disease.Semantic proximity Read ↗

Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease.Semantic proximity Read ↗

Diffusion Tensor MRI Structural Connectivity and PET Amyloid Burden in Preclinical Autosomal Dominant Alzheimer Disease: The DIAN Cohort.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.